These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 21802642)

  • 1. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
    Poon RT; Lau C; Yu WC; Fan ST; Wong J
    Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
    Poon RT; Ho JW; Tong CS; Lau C; Ng IO; Fan ST
    Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
    Leelawat K; Laisupasin P; Kiatdilokrut A; Pongtongpool T; Narong S; Samkhumphim N; Ket-Horm S
    J Med Assoc Thai; 2008 Oct; 91(10):1539-43. PubMed ID: 18972897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
    Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.